Pharmaron Biologics (Liverpool)
Liverpool, United Kingdom
Program data pending ClinicalTrials.gov matching
78.7
Signal Score
✓ FDA Inspections (3)
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
Quick Facts: Pharmaron Biologics (Liverpool)
- Signal Score
- 78.7/100
- Quality Compliance
- 100.0/100 — Bonus: 3 consecutive NAI inspections
- Headquarters
- Liverpool, United Kingdom
- Modalities
- AAV, Lentiviral, Adenoviral, Plasmid DNA, Recombinant Protein, Vaccines
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Pharmaron Biologics (Liverpool)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
100.0
Bonus: 3 consecutive NAI inspections
Source: FDA Data Dashboard
Bonus: 3 consecutive NAI inspections
FDA Inspections3 on record
Warning Letters0
Last InspectionNo Action Indicated (NAI) (2025-07-17)
Bonus: 3 consecutive NAI inspections
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Adenoviral, Plasmid DNA, Recombinant Protein, Vaccines
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (6 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press1 articles
Broad modality coverage (6 modalities)
Pharmaron Biologics (Liverpool) FDA Inspection History
2025-07
2025-01
2024-09
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2025-07-17 | Coventry, Rhode Island | Drug Quality Assurance | No | No Action Indicated (NAI) |
| 2025-01-17 | Exton, Pennsylvania | Human Cellular, Tissue, and Gene Therapies | No | No Action Indicated (NAI) |
| 2024-09-27 | Exton, Pennsylvania | Bioresearch Monitoring | No | No Action Indicated (NAI) |
Source: FDA Data Dashboard · Retrieved Jul 11, 2026
Recent News 1 articles
How HTPD transforms AAV process optimization and scale-up - News-Medical
Frequently Asked Questions About Pharmaron Biologics (Liverpool)
How many FDA inspections does Pharmaron Biologics (Liverpool) have on record?
CDMO Signal tracks 3 FDA inspections for Pharmaron Biologics (Liverpool), sourced from the FDA inspection database. See the full inspection history above.
Has Pharmaron Biologics (Liverpool) received an FDA warning letter?
CDMO Signal has no FDA warning letters on record for Pharmaron Biologics (Liverpool).
What is Pharmaron Biologics (Liverpool)'s CDMO Signal Score?
Pharmaron Biologics (Liverpool) has a Signal Score of 79/100, based on quality, operations, financial stability, and capacity data.
Evaluating Pharmaron Biologics (Liverpool) for a manufacturing program?
Use the free AI matchmaker to compare Pharmaron Biologics (Liverpool) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.1
AAV, Lentiviral, Plasmid DNA, Adenoviral, Plasmid
CoJourney Inc.
Horsham, PA (US HQ); Hangzhou, China (primary GMP manufacturing)
Signal Score: 60.0
Plasmid DNA, AAV, Adenoviral, Lentiviral, Retroviral, mRNA, sgRNA, Exosome
3P Biopharmaceuticals (now 3PBIOVIAN)
Pamplona-Noáin, Spain
Biologics (microbial & mammalian), AAV, Adenoviral, Lentiviral, Cell Therapy, Plasmid DNA, Recombinant Proteins, Biosimilars, Fill/Finish (recombinant proteins & viral vectors)
Rose BioSolutions
Wilmington, MA
Plasmid DNA, AAV, Lentiviral, Adenoviral, CAR-T, Cell Therapy, Gene Editing, Cell Solutions / Starting Materials
Advent Bioservices
London, United Kingdom
Signal Score: 78.1
AAV, Lentiviral, Adenoviral